BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36603652)

  • 1. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
    Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
    LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
    [No Abstract]   [Full Text] [Related]  

  • 3. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
    Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
    Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
    Morssinkhof MWL; Wiepjes CM; Bosman BW; Kinds J; Fisher AD; Greenman Y; Kreukels BPC; T'Sjoen G; van der Werf YD; Heijer MD; Broekman BFP
    Sleep Med; 2023 Jul; 107():316-326. PubMed ID: 37271109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
    Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
    Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
    Ong C; Monita M; Liu M
    Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
    Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
    J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy.
    Dix C; Moloney M; Tran HA; McFadyen JD
    Thromb Haemost; 2024 May; 124(5):387-398. PubMed ID: 37816389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
    Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
    J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment.
    Mazzoli F; Cassioli E; Ristori J; Castellini G; Rossi E; Cocchetti C; Romani A; Angotti T; Giovanardi G; Mosconi M; Lingiardi V; Speranza AM; Ricca V; Vignozzi L; Maggi M; Fisher AD
    J Endocrinol Invest; 2022 Nov; 45(11):2059-2068. PubMed ID: 35779204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review.
    Ferraro JJ; Reynolds A; Edoigiawerie S; Seu MY; Horen SR; Aminzada A; Hamidian Jahromi A
    World J Methodol; 2022 Nov; 12(6):465-475. PubMed ID: 36479311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.
    Green AE; DeChants JP; Price MN; Davis CK
    J Adolesc Health; 2022 Apr; 70(4):643-649. PubMed ID: 34920935
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.